Skip to content
PLXS

Plexus Corp.

Plexus Corp. Q1 FY2026 earnings call

January 29, 2026 · fiscal period ended 2025-12

EPS · actual vs est

/

Revenue · actual vs est

/
Ask about this call

Summary

Generated 2026-01-29

Management highlights

Management Statement and Operational Highlights

  • Plexus achieved significant momentum with strong year-over-year revenue growth in Q1 2026, meeting the midpoint of revenue guidance and having potential to exceed the 9%-12% goal for fiscal 2026.
  • Secured 22 new manufacturing programs worth $283 million in annualized revenue, with a record $220 million from Aerospace and Defense.
  • Demonstrated commitment to responsible innovation, with Penang, Malaysia team recognized for workplace awards and reducing environmental impact.
  • Voluntary Time Off charitable giving program saw donations to 24 global charities.
View in transcript ↓

Segment performance

Segment Performance

  • Aerospace and Defense: Fiscal first quarter revenue increased 3% sequentially. Fiscal second quarter expected to be up mid-single digits. Fiscal first quarter wins were $220 million. Anticipated 2026 revenue growth to exceed the 9%-12% goal.
  • Healthcare/Life Sciences: Fiscal first quarter revenue increased 10% sequentially. Fiscal second quarter expected flat to up low single digits. Fiscal first quarter wins of $40 million.
  • Industrial: Fiscal first quarter revenue declined 8% sequentially. Fiscal second quarter expected high single to low double-digit increase. Fiscal first quarter wins of $23 million. Funnel of qualified manufacturing opportunities at $3.6 billion.
View in transcript ↓

Guidance

Guidance

  • Fiscal second quarter revenue guided $1.11 billion to $1.15 billion (6% sequential, 15% year-over-year at midpoint).
  • Non-GAAP operating margin guided 5.6%-6.0%, non-GAAP EPS $1.80-$1.95.
  • Fiscal 2026 potential to meet/exceed the 9%-12% revenue growth goal.
  • Expected free cash flow of approximately $100 million for fiscal 2026.
  • Capital spending for fiscal 2026 now expected $100 million-$120 million.
View in transcript ↓

Risks

Risks

  • Supply chain lead time issues could impact program ramps and working capital.
  • Seasonal factors and variable compensation expenses may affect margins.
  • Global economic and market conditions could impact end market demand and revenue growth.
View in transcript ↓

Q&A highlights

Question and Answer

  • Q: What's changed over the last 3-6 months driving success? A: Todd Kelsey stated it's a combination of strong program wins and improved end markets, including semicap and Healthcare, with some Aerospace and Defense subsectors showing improvement.
  • Q: How long for semicap demand to translate to revenue? A: Todd Kelsey said demand increases show up in 1-2 quarters; capital/footprint changes take longer.
  • Q: Quantify Malaysia facility margin impact and outlook? A: Patrick Jermain said minimal headwind in Q1, close to breakeven in Q2, with Thailand facility expected to benefit margins 25-30 basis points.
  • Q: Impact of seasonal bonus on Q2 margins? A: Patrick Jermain said ~50-60 basis points headwind, offset by productivity improvements and revenue growth.
  • Q: Robotics program win in Industrial? A: Oliver Mihm said the customer is not new, but new region win with further opportunities in funnel.
View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS
Revenue

Transcript

January 29, 2026

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.